Soluble CD26 and CD30 levels in patients with common variable immunodeficiency

Journal of Investigational Allergology and Clinical Immunology

Volumn 23, Issue 2, 2013, Pages 120-124

  Mahmoudi, M ^a,b   Hedayat, M ^b,c   Aghamohammadi, A ^b   Rezaei, N ^b,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Common variable immune deficiency; Prognosis; Soluble CD26; Soluble CD30

Indexed keywords

CD30 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIGEN FUNCTION; ARTICLE; AUTOIMMUNITY; BLOOD ANALYSIS; BLOOD LEVEL; BRONCHIECTASIS; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME REGULATION; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; MALIGNANT NEOPLASTIC DISEASE; PHENOTYPE; PROGNOSIS; SPLENOMEGALY;

ADOLESCENT; ANTIGENS, CD30; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; DIPEPTIDYL PEPTIDASE 4; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; INFANT; MALE; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SOLUBILITY; SPLENOMEGALY; TH1-TH2 BALANCE; YOUNG ADULT;

EID: 84875461826     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aghamohammadi A, Parvaneh N, Rezaei N. Common variable immunodeficiency: a heterogeneous group needs further subclassification. Expert Rev Clin Immunol. 2009;5:629-31.
2. Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, Yaseri N, Movahedi M, Gharagozlou M, Zandieh F, Yazadni F, Arshi S, Mohammadzadeh I, Ghazi BM, Mahmoudi M, Tahaei S, Isaeian A. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol. 2005;12:825-32.
3. Aghamohammadi A, Moin M, Kouhi A, Mohagheghi MA, Shirazi A, Rezaei N, Tavassoli S, Esfahani M, Cheraghi T, Dastan J, Nersesian J, Ghaffari SR. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology. 2008;213:447-54.
4. Nourizadeh M, Aghamohammadi A, Moazzeni SM, Mahdavi M, Jalili A, Rezaei N, Hadjati J. Altered dendritic cell function in response to sera of common variable immunodeficiency patients. Inflamm Res. 2007;56:527-32.
5. Rezaei N, Aghamohammadi A, Nourizadeh M, Kardar GA, Pourpak Z, Zare A, Read RC. Cytokine production by activated T cells in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2010;20:244-51.
6. Rezaei N, Aghamohammadi A, Read RC. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease. Iran J Allergy Asthma Immunol. 2008;7:231-4.
7. Rezaei N, Aghamohammadi A, Siadat SD, Moin M, Pourpak Z, Nejati M, Ahmadi H, Kamali S, Norouzian D, Tabaraei B, Read RC. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol. 2008;15:607-11.
8. Rezaei N, Siadat SD, Aghamohammadi A, Moin M, Pourpak Z, Norouzian D, Mobarakeh JI, Aghasadeghi MR, Nejati M, Read RC. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency. Clin Vaccine Immunol. 2010;17:524-8.
9. Vodjgani M, Aghamohammadi A, Samadi M, Moin M, Hadjati J, Mirahmadian M, Parvaneh N, Salavati A, Abdollahzade S, Rezaei N, Srrafnejad A. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol. 2007;17:321-8.
10. Rezaei N, Aghamohammadi A, Kardar GA, Nourizadeh M, Pourpak Z. T-helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2008;18:449-53.
11. Gorrell MD, Gysbers V, McCaughan GW. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol. 2001;54:249-64.
12. Salgado FJ, Vela E, Martin M, Franco R, Nogueira M, Cordero OJ. Mechanisms of CD26/dipeptidyl peptidase IV cytokinedependent regulation on human activated lymphocytes. Cytokine. 2000;12:1136-41.
13. Willheim M, Ebner C, Baier K, Kern W, Schrattbauer K, Thien R, Kraft D, Breiteneder H, Reinisch W, Scheiner O. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol. 1997;100:348-55.
14. Horie R, Watanabe T. CD30: expression and function in health and disease. Semin Immunol. 1998;10:457-70.
15. Kadin ME. Regulation of CD30 antigen expression and its potential significance for human disease. Am J Pathol. 2000;156:1479-84.
16. Rezaei N, Haji-Molla-Hoseini M, Aghamohammadi A, Pourfathollah AA, Moghtadaie M, Pourpak Z. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J Clin Immunol. 2008;28:78-84.
17. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol. 1999;118 Suppl 1:1-28.
18. Aghamohammadi A, Abolhassani H, Moazzami K, Parvaneh N, Rezaei N. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Investig Allergol Clin Immunol. 2010;20:372-9.
19. Mohammadi J, Liu C, Aghamohammadi A, Bergbreiter A, Du L, Lu J, Rezaei N, Amirzargar AA, Moin M, Salzer U, Pan-Hammarstrom Q, Hammarstrom L. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol. 2009;29:777-85.
20. Rezaei N, Aghamohammadi A, Shakiba Y, Mahmoudi M, Jalali A, Moradi B, Amirzargar AA. Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol. 2009;150:1-7.
21. Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol. 2009;155:21-7.
22. Cordero OJ, Salgado FJ, Vinuela JE, Nogueira M. Interleukin-12-dependent activation of human lymphocyte subsets. Immunol Lett. 1998;61:7-13.
23. Seitzer U, Scheel-Toellner D, Hahn M, Heinemann G, Mattern T, Flad HD, Gerdes J. Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosy. Adv Exp Med Biol. 1997;421:217-21.
24. Busso N, Wagtmann N, Herling C, Chobaz-Peclat V, Bischof-Delaloye A, So A, Grouzmann E. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol. 2005;166:433-42.
25. Hildebrandt M, Rose M, Ruter J, Salama A, Monnikes H, Klapp BF. Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease. Scand J Gastroenterol. 2001;36:1067-72.
26. Kobayashi H, Hosono O, Mimori T, Kawasaki H, Dang NH, Tanaka H, Morimoto C. Reduction of serum soluble CD26/ dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. J Rheumatol. 2002;29:1858-66.
27. Martinez-Pomar N, Raga S, Ferrer J, Pons J, Munoz-Saa I, Julia MR, de Gracia J, Matamoros N. Elevated serum interleukin (IL)- 12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol. 2006;144:233-8.
28. North ME, Webster AD, Farrant J. Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets. Clin Exp Immunol. 1998;111:70-5.
29. Cambronero R, Sewell WA, North ME, Webster AD, Farrant J. Up- regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol. 2000;164:488-94.
30. Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, Yang Z, Yi C, Quezado M, Brown M, Strober W. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131:748-56.
31. Fischer MB, Hauber I, Vogel E, Wolf HM, Mannhalter JW, Eibl MM. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol. 1993;92:340-52.
32. Pons J, Ferrer JM, Martinez-Pomar N, Iglesias-Alzueta J, Matamoros N. Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease. Scand J Immunol. 2006;63:383-9.
33. Pellegrini P, Berghella AM, Contasta I, Adorno D. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Transpl Immunol. 2003;12:49-61.
34. Pellegrini P, Totaro R, Contasta I, Berghella AM, Carolei A, Adorno D. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis. Neuroimmunomodulation. 2005;12:220-34.
35. Contasta I, Berghella AM, Pellegrini P, Adorno D. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. Cancer Biother Radiopharm. 2003;18:549-57.